Investigator-initiated trial of crofelemer for congenital diarrheal disorders (CDDs) in children.

Trial Profile

Investigator-initiated trial of crofelemer for congenital diarrheal disorders (CDDs) in children.

Planning
Phase of Trial: Phase II

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Crofelemer (Primary)
  • Indications Congenital disorders; Diarrhoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jan 2018 New trial record
    • 22 Jan 2018 According to a Jaguar Health media release, Napo has accepted a request for support submitted by Dr. Mohamad Miqdady, Chief of Pediatric Gastroenterology, Hepatology and Nutrition at Sheikh Khalifa Medical City (SKMC) in Abu Dhabi, for this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top